Scotland Backs Bayer's Xofigo In Prostate Cancer Before England
This article was originally published in Scrip
The Scottish Medicines Consortium (SMC) has published advice accepting six new medicines for use in NHS Scotland, three of which have yet to receive final vetting from NICE – the HTA body for England and Wales.
You may also be interested in...
Roche’s Q1 update highlighted some key coming drug catalysts and early stage clinical efforts, including those for a potential COVID pill and for targeted cancer vaccines.
Biosimilar erosion and slack drugs sales caused by the pandemic depressed Roche’s first quarter pharma revenue while its diagnostics unit saw sales soar on COVID testing.
Although 2020 was the best year ever for Swiss biotech financing activities, no domestic IPOs were launched by the sector. But introducing the SPAC might change that.